• Arvato Systems adds Eqeep as implementation partner for serialization solution in the Dutch and Belgian healthcare markets
  • Partnership is expected to expand into further business areas in the future

International initiatives aim to prevent fake medications from entering the legal supply chain. Arvato CSDB, the serialization solution from Arvato Systems, enables pharmaceutical companies to serialize medical products. Arvato Systems and Eqeep Consulting B.V. have agreed to enter into a partnership for the implementation of this IT solution. Further joint projects and training by Eqeep for customers in the serialization environment are planned for the future.

In line with the EU anti-counterfeiting directive (Falsified Medicines Directive, or FMD), agreed by the EU in January 2016, from February 9, 2019 prescription medicines can only be sold if each individual package can be identified as unique and is provided with a serial number. These serial numbers are added to a national database: when medications are given to customers, the pharmacy confirms that the serial number is in existence and has not previously been used. The Arvato CSDB serialization solution is a fully integrated modular system which ensures that companies are able to implement the FMD.

Harm van Echteld, CEO of Eqeep Group B.V. welcomes the partnership with Arvato Systems and highlights the need for practical action in the pharmaceutical industry: “Serialization brings with it considerable additional effort for companies. Many still underestimate how much work will be needed to ensure that all systems and processes have been modified in good time. For us, this partnership offers a perfect opportunity to expand our market knowledge. We have already had experience of working closely with Arvato Systems, and this was a partnership that felt very positive. Building from this, we have now taken the next step. We will help Arvato Systems’ customers to implement the serialization solution Arvato CSDB, so that customers are able to demonstrate compliance with the European Counterfeit Medication directive in good time.”

As well as the implementation, Arvato Systems and Eqeep expect their future work together to extend to other areas such as managed services in combination with IFS Enterprise Business Software products.

About Eqeep
Based in Tiel (Netherlands) and Herford (Germany), the Eqeep Group advises and supports mostly international companies to effectively organize their IT processes and achieve their business objectives. www.eqeep.nl

Photo (left to right):

Harm van Echteld, Director, Eqeep Group B.V.
Anatol Wiebe, Director Track and Trace, Arvato Systems
Peter Stemerdink, Key Account Manager, Arvato Systems
Yves Chin, Business Consultant, Eqeep Consulting B.V.
Oliver Meihorst, Senior Account Manager Pharma, Arvato Systems

Über die Arvato Systems GmbH

Global IT specialist Arvato Systems supports major companies through digital transformation. More than 3,000 staff in over 25 locations epitomize in-depth technology expertise, industry knowledge and focus on customer requirements. Working as a team, we develop innovative IT solutions, transition our clients into the Cloud, integrate digital processes and take on IT systems operation and support. As a part of the Bertelsmann-owned Arvato network, we have the unique capability to work across the entire value chain. Our business relationships are personal; we work with our clients as partners, so that together we can achieve long-term success. IT.arvato.com

Firmenkontakt und Herausgeber der Meldung:

Arvato Systems GmbH
An der Autobahn 200
33333 Gütersloh
Telefon: +49 (5241) 80-80888
Telefax: +49 (5241) 80-80666

Marcus Metzner
Chief Marketing Officer
Telefon: +49 (5241) 80-88242
Fax: +49 (5241) 80-9568
E-Mail: Marcus.Metzner@bertelsmann.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.